Viewing Study NCT00254735


Ignite Creation Date: 2025-12-24 @ 10:22 PM
Ignite Modification Date: 2025-12-25 @ 7:55 PM
Study NCT ID: NCT00254735
Status: COMPLETED
Last Update Posted: 2007-12-18
First Post: 2005-11-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Quetiapine Augmentation in Severe Obsessive Compulsive Disorder
Sponsor: AstraZeneca
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-04
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2006-03
Completion Date Type: ACTUAL
First Submit Date: 2005-11-15
First Submit QC Date: None
Study First Post Date: 2005-11-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2007-12-14
Last Update Post Date: 2007-12-18
Last Update Post Date Type: ESTIMATED